HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Helen McIlleron Selected Research

lopinavir (Kaletra)

1/2014Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy.
11/2013Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin.
1/2012Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children.
1/2012The safety, effectiveness and concentrations of adjusted lopinavir/ritonavir in HIV-infected adults on rifampicin-based antitubercular therapy.
1/2011Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis.
10/2010Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Helen McIlleron Research Topics

Disease

27Tuberculosis (Tuberculoses)
01/2015 - 11/2005
8Pulmonary Tuberculosis
09/2013 - 07/2005
5Infection
01/2014 - 04/2006
5Body Weight (Weight, Body)
08/2012 - 04/2006
3HIV Infections (HIV Infection)
06/2015 - 06/2009
2Neutropenia
02/2015 - 01/2014
1Uveitis
01/2014
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
07/2012
1Nausea
01/2012
1Diarrhea
01/2012
1Acquired Immunodeficiency Syndrome (AIDS)
01/2010
1Kwashiorkor
06/2009
1Immune Reconstitution Inflammatory Syndrome
11/2007
1Drug Toxicity (Drug Safety)
11/2007
1Falciparum Malaria (Plasmodium falciparum Malaria)
11/2006
1Malaria
11/2006

Drug/Important Bio-Agent (IBA)

20Rifampin (Rifampicin)FDA LinkGeneric
01/2015 - 07/2005
10Isoniazid (Ftivazide)FDA LinkGeneric
01/2015 - 04/2006
9PyrazinamideFDA LinkGeneric
01/2015 - 04/2006
6Ethambutol (Myambutol)FDA LinkGeneric
01/2015 - 04/2006
6Ritonavir (Norvir)FDA Link
01/2014 - 10/2010
6lopinavir (Kaletra)FDA Link
01/2014 - 10/2010
5Carbon MonoxideIBA
01/2014 - 11/2007
3Nevirapine (Viramune)FDA Link
07/2012 - 02/2008
2Protease Inhibitors (Protease Inhibitor)IBA
06/2015 - 01/2014
2Rifabutin (Ansamycin)FDA Link
02/2015 - 01/2014
2gatifloxacin (Zymar)FDA Link
09/2013 - 12/2007
2rifapentine (Priftin)FDA Link
11/2005 - 07/2005
1rifamycin SVIBA
06/2015
1efavirenz (Sustiva)FDA Link
01/2015
1Lamivudine (3TC)FDA Link
08/2012
1FluoroquinolonesIBA
07/2012
1Ofloxacin (Levofloxacin)FDA LinkGeneric
07/2012
1Interferon-gamma (Interferon, gamma)IBA
11/2007
1AntigensIBA
11/2007
1artesunateIBA
11/2006
1Antimalarials (Antimalarial Agents)IBA
11/2006
1dihydroquinghaosu (dihydroartemisinin)IBA
11/2006

Therapy/Procedure

5Drug Therapy (Chemotherapy)
01/2014 - 11/2007